Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Pneumonia bacterial

Recruiting

Registered drugNo placebo

Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Ampicillin Sodium

Contact Research Centre

Follicular lymphoma

Recruiting

Registered drugNo placebo

Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis

Recruiting

Investigational

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational

Greece

Participants:18–64 years · 65+ years

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

Registered drugNo placebo

Greece

Participants:18–64 years
Substances:Atezolizumab

Contact Research Centre

Helicobacter infection

Recruiting

Registered drugNo placebo

Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Amoxicillin

Contact Research Centre

Non-small cell lung cancer stage III

Recruiting

Registered drugNo placebo

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer stage IV

Recruiting

Registered drug

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Endocrine ophthalmopathy

Recruiting

InvestigationalNo placebo

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:AMG 732

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Investigational

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Nipocalimab

Contact Research Centre

Chronic myeloid leukaemia

Recruiting

Registered drugNo placebo

Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

Registered drugNo placebo

Greece

Participants:0–17 years
Substances:Asciminib Hydrochloride

Contact Research Centre

Find therapies in clinical trials near you – page 8

1 084 trials match your criteria

B-cell type acute leukaemia

Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Non-small cell lung cancer

Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Pneumonia bacterial

Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

Follicular lymphoma

Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

Metabolic dysfunction-associated steatohepatitis

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Small cell lung cancer extensive stage

Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

Helicobacter infection

Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

Non-small cell lung cancer stage III

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Non-small cell lung cancer stage IV

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Endocrine ophthalmopathy

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Systemic lupus erythematosus

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Chronic myeloid leukaemia

Asciminib in Pediatric Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.